Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIndivior Share News (INDV)

Share Price Information for Indivior (INDV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,445.00
Bid: 1,435.00
Ask: 1,437.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.139%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,445.00
INDV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET OPEN: Energean Drops Norway Assets From Edison Deal

Mon, 29th Jun 2020 08:57

(Alliance News) - Stock prices in London opened marginally higher on Monday despite persistent health fears after the global coronavirus death toll moved past 500,000.

The FTSE 100 index was up 4.71 points, or 0.1%, at 6,154.92. The mid-cap FTSE 250 index was up 18.92 points, or 0.1%, at 17,132.09. The AIM All-Share index was up 2.62 points, or 0.3%, at 885.76.

The Cboe UK 100 index was down 0.4% at 10,399.43. The Cboe 250 was down 0.4% at 14,561.10, and the Cboe Small Companies was flat at 9,319.59.

In mainland Europe, the CAC 40 in Paris was down 0.4%, while the DAX 30 in Frankfurt was flat.

Data showed more than half a million people died globally due to the coronavirus pandemic, according to an AFP tally on Sunday, as bars in Los Angeles were ordered to close again due to surging cases in the US.

The worldwide number of recorded infections is now just over 10 million from the virus that first emerged in China late last year, with fears growing of a full-blown second wave. The rate of contagion has doubled since May 21.

Infections are up too in some other parts of the world that have reopened, with Europe registering a caseload of over 2.6 million, although daily rates have stabilised.

"The market remains relatively sanguine by the deteriorating health situation in Florida and Texas, as improving cyclical data is keeping investor sentiment afloat for now. The rate of positive tests is 14.7% in Florida and 14.3% in Texas, according to state data. The trajectory for...equities depends on the likelihood of renewed lock-downs. The high economic costs mean the bar is set very high for economic closures," said AxiCorp's Stephen Innes.

In the FTSE 100, Rio Tinto was down 1.0%. The Anglo-Australian miner said it has reached an agreement with the government of Mongolia on a new source of domestic power for its Oyu Tolgoi copper and gold mine.

Rio said the agreement paves the way for the government to fund and construct a state-owned power plant at Tavan Tolgoi. The miner also said the two sides would work towards finalising a power purchase agreement by the end of March 2021.

Construction of the coal-fired power plant will begin no later than July 2021.

In the FTSE 250, Energean was the best performer, up 13% after the oil and gas company amended the terms for its acquisition of Italian utility Edison's exploration & production portfolio.

Energean said the deal now will exclude Edison's Norwegian subsidiary. The latest change follows the exclusion of Edison's Algerian asset. The purchase is now valued at USD284 million, as opposed to the original sum of USD750 million.

It still includes Edison's UK portfolio, with a stake in Glengorm, the largest gas condensate discovery in the Central North Sea.

Elsewhere, Indivior was down 1.2% after the drugmaker said it has promoted Chief Financial & Operations Officer Mark Crossley to chief executive officer to replace Shaun Thaxter, who is stepping down. Crossley has been CFOO of Indivior since February 2017 and joined Indivior in 2012. Indivior said Ryan Preblick, currently SVP of global financial planning & analysis commercial operations, has been appointed interim CFO.

The Japanese Nikkei 225 index closed down 2.3%. In China, the Shanghai Composite ended down 0.7%, while the Hang Seng index in Hong Kong is down 1.1%. The Shanghai market reopened on Monday after being closed on Thursday and Friday for the Dragon Boat Festival holiday.

The pound was quoted at USD1.2366 early Monday, up from USD1.2326 at the London equities close on Friday.

The EU and the UK launch an intense five weeks of negotiations on a deal to define their post-Brexit relations on Monday, with London keen to wrap things up quickly. The new round of talks in Brussels will be the first to be held face-to-face since the coronavirus shutdown combined with the two sides' entrenched positions to stall progress.

The euro was quoted at USD1.1248, up from USD1.1210 late Friday in London. Against the yen, the dollar was trading at JPY107.12 in London, marginally lower than JPY107.21 on Friday.

Gold was quoted at USD1,773.84 an ounce, up from USD1,760.70 late Friday. The precious metal hit a high of USD1,775.67 overnight - its highest level since late 2012.

Brent oil was quoted at USD40.26 a barrel Monday morning, lower from USD40.70 late Friday.

The economic events calendar on Monday has Germany inflation readings at 1300 BST.

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
21 Aug 2023 07:23

Indivior settles part of US suboxone litigation

(Sharecast News) - Addiction treatment specialist Indivior announced on Monday that its US subsidiary has entered into an agreement to settle the claims initiated by the end payor class in the ongoing multi-district suboxone antitrust litigation.

Read more
1 Aug 2023 17:39

TRADING UPDATES: C4X Discovery inks Indivior deal, Digitalbox expands

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
28 Jul 2023 09:46

LONDON BROKER RATINGS: KBW cuts Aviva 'market perform'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

Read more
27 Jul 2023 11:48

Indivior raises 2023 guidance after strong half-year progress

(Alliance News) - Indivior PLC on Thursday celebrated a strong recent six months and second quarter that brough increased profit and revenue, boosting its optimism for the rest of the year.

Read more
27 Jul 2023 10:04

Indivior lifts guidance after strong first half

(Sharecast News) - Pharmaceuticals firm Indivior reported a 24% improvement in net revenue in its half-year report on Thursday, to $529m.

Read more
12 Jun 2023 07:53

LONDON BRIEFING: Shares on the rise; Frasers buys into AO World

(Alliance News) - Stocks in London were set to open higher on Monday, at the start of a busy week of central bank moves.

Read more
5 Jun 2023 07:46

Indivior reaches settlement in litigation with US states

(Sharecast News) - Addiction treatment-focussed pharmaceuticals company Indivior announced on Monday that its subsidiary Indivior Inc has successfully reached an agreement to resolve the claims brought against it by the attorneys general of 41 US states and the District of Columbia.

Read more
2 Jun 2023 18:18

Indivior settles antitrust claims in US regarding Suboxone drug

(Alliance News) - Indivior PLC on Friday said it has reached an agreement to resolve the claims brought in antitrust multi-district litigation regarding its drug Suboxone.

Read more
25 May 2023 09:23

LONDON BROKER RATINGS: Numis starts Tristel with 'add'

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
23 May 2023 09:56

Indivior emergency opioid overdose treatment approved by US FDA

(Alliance News) - Indivior PLC on Tuesday said the US Food & Drug Administration has approved its OPVEE nasal spray for the emergency treatment of opioid overdose.

Read more
23 May 2023 07:48

Indivior's opioid addiction sprat approved by FDA

(Sharecast News) - US health regulators have approved Indivior's Opvee nasal spray treatment for opiod addiction, the company said on Tuesday.

Read more
10 May 2023 17:02

DIRECTOR DEALINGS: Indivior division chief sells GBP1.7 million shares

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Wednesday and not separately reported by Alliance News:

Read more
27 Apr 2023 15:49

UK shareholder meetings calendar - next 7 days

Friday 28 April 
AQRU PLCAGM
Audioboom Group PLCAGM
BBGI Global Infrastructure SAAGM
Everest Global PLCAGM
GetBusy PLCAGM
Greencoat Renewables PLCAGM
Greencoat UK Wind PLCAGM
Hikma Pharmaceuticals PLCAGM
JPMorgan Claverhouse Investment Trust PLCAGM
Kingspan Group PLCAGM
ME Group International PLCAGM
Minoan Group PLCAGM
Pearson PLCAGM
Rotork PLCAGM
Shanta Gold LtdAGM
Smurfit Kappa Group PLCAGM
Symphony International Holdings LtdAGM
Monday 1 May 
no events scheduled 
Tuesday 2 May 
Carr's Group PLCGM re annual report and directors remuneration report
CVC Income & Growth LtdAGM
IOG PLCAGM
Ocado Group PLCAGM
Plus500 LtdAGM
Wednesday 3 May 
Apax Global Alpha LtdAGM
Barclays PLCAGM
GSK PLCAGM
Hyve Group PLCCourt Meeting & GM re acquisition by Heron UK Bidco Ltd
Logistics Development Group PLCAGM
Okyo Pharma LtdGM re proposed cancellation of the ordinary shares of no par value
Reach PLCAGM
Reckitt Benckiser Group PLCAGM
Standard Chartered PLCAGM
Tritax Big Box REIT PLCAGM
Unilever PLCAGM
Thursday 4 May 
AIB Group PLCAGM
Aviva PLCAGM
Aviva PLCGM re capital reduction
BAE Systems PLCAGM
Bivictrix Therapeutics PLCAGM
Domino's Pizza Group PLCAGM
Glanbia PLCAGM
Grafton Group PLCAGM
Hammerson PLCAGM
Howden Joinery Group PLCAGM
Hurricane Energy PLCCourt Meeting & GM re takeover by Prax Exploration & Production PLC  
Indivior PLCAGM
IMI PLCAGM
Irish Residential Properties REIT PLCAGM
ITV PLCAGM
Jardine Matheson Holdings LtdAGM
Johnson Service Group PLCAGM
LungLife AI IncAGM
Mincon Group PLCAGM
Mondi PLCAGM
Moneysupermarket.com Group PLCAGM
Morgan Sindall Group PLCAGM
Spirent Communications PLCAGM
Personal Group Holdings PLCAGM
Phoenix Group Holdings PLCAGM
Rathbones Group PLCAGM
SIG PLCAGM
Ten Entertainment Group PLCAGM
Travis Perkins PLCAGM
Witan Investment Trust PLCAGM
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
27 Apr 2023 14:41

Indivior lifts revenue guidance, cuts profit outlook after Opiant deal

(Sharecast News) - Opioid addiction treatment maker Indivior lifted its full-year revenue guidance on Thursday but trimmed its outlook for operating profit due to costs related to the acquisition of Opiant Pharmaceuticals, as it posted a jump in first-quarter profit and revenue.

Read more
27 Apr 2023 13:46

Indivior raises 2023 revenue forecast following Opiant acquisition

(Alliance News) - Indivior PLC on Thursday said net revenue increased by more than 20% in the first quarter, lifting profit, and it updated its guidance for the year following its acquisition of Opiant Pharmaceuticals Inc last month.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.